April 13, 2022 | Press Releases SCIENION celebrates the laying of the foundation stone for new headquarters in Berlin Adlershof
March 2, 2022 | Press Releases The study demonstrated the success of an optofluidic-based Point-of-Care (PoC) diagnostic system for the analysis of protein-protein interactions. Today SCIENION, a BICO company and leading […] SCIENION Announces Study Results for PoC-BoSens, an Optofluidic-based Infectious Disease Diagnostic Platform
January 19, 2022 | Press Releases The breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care […] SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform
November 3, 2021 | Press Releases Available today, the proteoCHIP 12*16 facilitates automated, miniaturized solutions for single cell proteomics applications Today, SCIENION & Cellenion, BICO companies, announced the release of the […] SCIENION & Cellenion Announce the Launch of the proteoCHIP 12*16 for Single Cell Proteomics Sample Preparation on the cellenONE® Platform
October 27, 2021 | Press Releases The new platform broadens Cellenion’s single cell dispensing solutions portfolio by enabling the isolation and handling of cellular aggregates from 80 µm to 600 µm […] SCIENION & Cellenion Launch spheroONE®, a Large-Particle Sorter and Dispenser to Advance Drug Testing on Complex In-Vitro 3D Models
September 28, 2021 | Press Releases The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance […] SCIENION and Pictor Limited Partner to Commercialize High-Throughput SARS-CoV-2 Antibody Testing System to Support Ongoing Fight Against Pandemic
August 30, 2021 | Company News Since its foundation in 2001, SCIENION GmbH has been located in the Adlershof Science & Technology Park in Berlin, Germany. The life sciences company is […] Preview of SCIENION’s new headquarters in Berlin-Adlershof
August 26, 2021 | Press Releases The two companies will work with the Environmental Molecular Science Laboratory, a U.S. Department of Energy user facility located at PNNL, and will leverage Cellenion’s [...] SCIENION and Cellenion Exclusively License PNNL-Developed Tech and Partner to Accelerate Sample Processing for Mass-Spectrometry
March 18, 2021 | Company News Potsdam and Berlin, Germany; March, 18, 2021: GILUPI GmbH and SCIENION AG today announced that the companies intend to intensify their collaboration in the field […] GILUPI and SCIENION announce collaboration for the development of Single-Cell CTC Analysis
February 15, 2021 | Press Releases CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the shareholders of Ginolis Oy (“Ginolis”), a Finnish company focusing on diagnostics automation and advanced […] CELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis
February 3, 2021 | Company News Berlin, 3. Februar, 2021: Die SCIENION AG, die bereits seit Firmengründung 2001 im Technologiepark Adlershof ansässig ist, vergrößert sich weiter und baut ihren neuen Hauptsitz […] SCIENION AG expandiert weiter und baut neue Unternehmenszentrale in Berlin Adlershof
February 3, 2021 | Press Releases Berlin, Germany; February, 3, 2021: SCIENION AG, located in the Technology Park Adlershof since its foundation in 2001, today announced that the expanding company will […] SCIENION continues to grow and will build new headquarters in Berlin Adlershof